Promega builds plant to produce regulated products

Published: 29-Aug-2011
Manufacturing Analysis

Including sample preparation systems and reagents

Promega Corporation, based in Madison, Wisconsin, US, has held a ground-breaking ceremony for a new cGMP facility to support business growth and customers who need FDA-regulated molecular biology products. These include sample preparation systems and reagents, which are part of diagnostic and medical tests sold by human diagnostic test providers.

The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.

‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.

Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.

Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.

See more

You may also like

Ingredients

Promega unveils cellular target engagement technology

Read more
TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
  3. Freudenberg Medical launches CleanAssure ISO Class 5 cleanroom service for sterile single-use biopharma assemblies CleanAssure is an ISO Class 5 controlled cleanroom service delivering washed, dried and gamma-sterilised single-use assemblies to biopharmaceutical customers, addressing industry challenges around cleaning validation and contamination risk
  4. First aid readiness in analytical laboratories Preparing for chemical emergencies with specialist equipment and training
  5. Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Ingredients

Promega unveils cellular target engagement technology

TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery
Manufacturing

Promega opens new Shanghai facility

Provides additional r&d and cGMP manufacturing capabilities
Manufacturing

DINAMIQS secures Swissmedic licence for viral vector GMP manufacturing at Zurich facility

Siegfried-owned DINAMIQS has gained Swissmedic approval to manufacture and release ATMPs, establishing itself as Switzerland’s first fully integrated viral vector CDMO with end-to-end cGMP capabilities.
Manufacturing

VIVEbiotech and Zelluna expand lentiviral vector partnership to advance off-the-shelf TCR-NK therapy for solid tumours

The pair have announced an update to their long-standing manufacturing partnership, advancing lentiviral vector production for Zelluna's lead TCR-NK programme, ZI-MA4-1, targeting the MAGE-A4 tumour antigen, which is planned to enter clinical trials in 2026
Manufacturing

Romaco unveils the KTS 840 at interpack - Powerful tableting technology for triple-layer tablets

Karlsruhe/Germany, 2026-04-28 - At interpack 2026, Romaco Kilian will be presenting the KTS 840 – its new tablet press for triple-layer applications. This robust rotary tablet press was specially designed for use in the nutraceutical and food industries. In addition, Romaco will join with Theegarten-PACTEC to exhibit a high speed line for compressing and packaging bouillon cubes. With the KTP 1X compaction simulator, Romaco will showcase its expertise in research and development
Manufacturing

Ecolab Life Sciences opens bioprocessing applications lab in Korea to support downstream process development across Asia

New facility serves biopharma manufacturers throughout the region with local access to customer purification studies across Ecolab's Purolite Resin portfolio
Manufacturing

L.B. Bohle will exhibit a wide range of its advanced machinery at Interpack 2026

L.B. Bohle has been a leading exhibitor at interpack, one of Europe’s leading packaging and process expos for many years. For 2026, it will exhibit under its own banner from Booth B41 In Hall 16 of the Düsseldorf Messe expo center
Subscribe now